Provectus Biopharmaceuticals, Inc. (PVCT) plummeted -1.96 percent and ended the day at $0.05. The Average Volume of the company is 1.12 Million.

The highest price PVCT stock touched in the last 12 month was $0.06 and the lowest price it hit in the same period was $0.05. The company’s market cap is $18.52 Million.

A price target is the projected price level of a financial security stated by an investment analyst. It represents a security’s price that, if achieved, results in a trader recognizing the best possible outcome for his investment. This is the price at which the trader or investor wants to exit his existing position so he can realize the most reward.

Provectus Biopharmaceuticals, Inc. (PVCT) has been given an average price target of $3.5 from analysts, according to data collected by Finviz.

Now we look at the Moving Averages, the 200-day is -2.44, the 50-day is -2.44 and the 20-day is -2.44. Moving averages are used as a strong indicator for technical stock analysis and it helps investors in figuring out where the stock has been and also help in determining where it may be possibly heading.

Provectus Biopharmaceuticals, Inc. (PVCT) performance during the last one year Improved 0 percent, while its year to date (YTD) performance showed a Positive trend of 0 percent. The stock Jumped 0 percent over the past six months. The stock’s quarterly performance indicates a Positive momentum of 0 percent, whereas its last one month trend is Optimistic with 0 percent. Its weekly performance showed downward trend of -1.96 percent.

Provectus Biopharmaceuticals, Inc. (PVCT) has 370.36 Million shares outstanding and 350.77 Million shares were floated in market. The short ratio in the company’s stock is documented at 1.62 and the short float is around of 0.52%. The stock’s average true range of stands at 0.01.